Grove Bank & Trust’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.3K Hold
176
﹤0.01% 632
2026
Q1
$12.5K Hold
176
﹤0.01% 594
2025
Q4
$14.4K Hold
176
﹤0.01% 585
2025
Q3
$13.2K Sell
176
-29
-14% -$2.16K ﹤0.01% 572
2025
Q2
$15.2K Buy
205
+19
+10% +$1.32K ﹤0.01% 564
2025
Q1
$15K Buy
186
+100
+116% +$8.59K ﹤0.01% 559
2024
Q4
$6.72K Buy
86
+9
+12% +$765 ﹤0.01% 571
2024
Q3
$7.23K Buy
77
+25
+48% +$2.1K ﹤0.01% 526
2024
Q2
$4.05K Hold
52
﹤0.01% 526
2024
Q1
$4.73K Hold
52
﹤0.01% 538
2023
Q4
$4.02K Hold
52
﹤0.01% 540
2023
Q3
$3.54K Sell
52
-833
-94% -$60.6K ﹤0.01% 604
2023
Q2
$71.9K Sell
885
-40
-4% -$3.19K 0.01% 326
2023
Q1
$75.9K Buy
+925
New +$66K 0.02% 325

Other funds holding GEHC

Grove Bank & Trust's GEHC Position: Q2 2026 in Review

Grove Bank & Trust held its GE HealthCare (GEHC) position steady in Q2 2026 at 176 shares worth $11.3K. The position accounts for ﹤0.01% of the portfolio, ranked #632.

Grove Bank & Trust first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $75.9K in Q1 2023. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Grove Bank & Trust held 176 shares of GE HealthCare worth $11.3K as of Q2 2026.
  • Grove Bank & Trust left its GE HealthCare share count unchanged in Q2 2026.
  • GE HealthCare made up ﹤0.01% of Grove Bank & Trust's portfolio in Q2 2026, its #632 holding.
  • Grove Bank & Trust first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Grove Bank & Trust's GE HealthCare position peaked at $75.9K in Q1 2023.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Grove Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.